GEN Exclusives

More »

GEN News Highlights

More »
Feb 13, 2009

Expression Analysis to Offer Genomic Services in U.K. through Partnership with Geneblitz

  • Expression Analysis entered a partnership with Complement Genomics, holding company of Geneblitz, to offer its genomic services for clinical trials and research to the U.K. market.

    Geneblitz provides a range of services to the biotechnology sector, such as genotyping, DNA sequencing, forensic testing, and a number of toxicology and drug analysis protocols in addition to its own research programs in wound care. 

    "The partnership with Geneblitz provides us an established presence in the U.K., with an experienced service provider who operates with the same philosophy and similar quality standards and platforms," says Steve McPhail, president and CEO of Expression.

    The Geneblitz agreement with its emphasis on genome-wide association studies is reflective of Expression Analysis' growing activity in this area, McPhail adds.

    Expression Analysis' genomic services include whole genome to focused-set gene expression and genotyping assays as well as sequencing services.

     



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?